ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

Continue Reading

Wife, mother of two in remission thanks to experimental CAR T cell therapy

December 20, 2018 | Leti Marquez & Zen Vuong

Meet float rider Cheryl Wiers, a wife and mother of two who battled cancer twice only to have it return. She eventually found prolonged remission thanks to a CAR T Cell therapy offered at City of Hope.

City of Hope to offer CAR T cell therapy for patients with the most common type of NHL

May 4, 2018 | Letisia Marquez

City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

City of Hope to Provide First FDA-approved CAR T Cell Therapy for Some Types of Lymphoma

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR T therapy for adult patients who have not responded to or who have relapsed after at least two other kinds of treatment.

Caregiver, Cancer Survivor and Author: City of Hope Nurse Christine Magnus Moore

June 5, 2017 | Michael Easterling

As an oncology nurse, Christine Magnus Moore, R.N., B.S.N., has cared for patients going through the most challenging circumstances one can imagine. But she didn’t fully comprehend the courage of these cancer patients until she became one herself.